India's Glenmark Pharma posts loss for Q3 as remediation cost weighs

HYDERABAD (Reuters) - India's generic drugmaker Glenmark Pharmaceuticals posted a quarterly loss for the second time straight, hurt by higher expenses ...

Related Keywords

United States ,India ,Hyderabad ,Andhra Pradesh ,America ,Shweta Agarwal ,Glen Saldanha ,Rishika Sadam ,Glenmark Life Sciences ,Glenmark Pharmaceuticals ,Us Department Of Justice ,Director Glen Saldanha ,North America ,